In the current study, we first detected BCL6 expression in breast cancer vs. breast benign disease tissue specimens and found that levels of BCL6 mRNA and protein were significant higher in breast cancer tissues than in breast benign disease tissues. This evidence concerns the gene BCL6 and breast carcinoma.